[A rational approach to the treatment of diffuse large-cell lymphomas].
Larsen
Christian-Jacques
CJ
D000818:Animals; D017076:Computer-Aided Design; D015195:Drug Design; D004354:Drug Screening Assays, Antitumor; D020868:Gene Silencing; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy* / Q000235:genetics; D051379:Mice; D009363:Neoplasm Proteins / Q000037:antagonists & inhibitors* / Q000235:genetics; D056971:Nuclear Receptor Co-Repressor 1 / Q000378:metabolism; D056985:Nuclear Receptor Co-Repressor 2 / Q000378:metabolism; D051560:Proto-Oncogene Proteins c-bcl-6 / Q000037:antagonists & inhibitors* / Q000235:genetics; D014158:Transcription, Genetic / Q000187:drug effects
C539127:NCOR1 protein, human; D009363:Neoplasm Proteins; D056971:Nuclear Receptor Co-Repressor 1; D056985:Nuclear Receptor Co-Repressor 2; D051560:Proto-Oncogene Proteins c-bcl-6